Post-tuberculosis lung health: perspectives from the First International Symposium
- PMID: 32912387
- DOI: 10.5588/ijtld.20.0067
Post-tuberculosis lung health: perspectives from the First International Symposium
Abstract
ALTHOUGH CURABLE, TB frequently leaves the individual with chronic physical and psycho-social impairment, but these consequences have been largely neglected. The 1st International Post-Tuberculosis Symposium (Stellenbosch, South Africa) was held to discuss priorities and gaps in addressing this issue. A barrier to progress has been the varied terminology and nomenclature, so the Delphi process was used to achieve consensus on definitions. Lack of sufficient evidence hampered definitive recommendations in most domains, including prevention and treatment of post-TB lung disease (PTLD), but the discussions clarified the research needed. A consensus was reached on a toolkit for future PTLD measurement and on PTLD patterns to be considered. The importance of extra-pulmonary consequences and progressive impairment throughout the life-course was identified, including TB recurrence and increased mortality. Patient advocates emphasised the need to address the psychological and social impacts post TB and called for clinical guidance. More generally, there is an urgent need for increased awareness and research into post-TB complications.
Comment in
-
Post-tuberculosis sequelae: the need to look beyond treatment outcome.Int J Tuberc Lung Dis. 2020 Aug 1;24(8):761-762. doi: 10.5588/ijtld.20.0488. Int J Tuberc Lung Dis. 2020. PMID: 32912378 No abstract available.
-
Taking action to improve post-TB lung health.Int J Tuberc Lung Dis. 2021 Feb 1;25(2):161-162. doi: 10.5588/ijtld.20.0861. Int J Tuberc Lung Dis. 2021. PMID: 33656433 No abstract available.
-
Reply to: Taking action to improve post-TB lung health.Int J Tuberc Lung Dis. 2021 Feb 1;25(2):163a-163. doi: 10.5588/ijtld.20.0902. Int J Tuberc Lung Dis. 2021. PMID: 33656434 No abstract available.
-
Clinical care for patients with post-TB lung disease.Int J Tuberc Lung Dis. 2021 Mar 1;25(3):252-253. doi: 10.5588/ijtld.20.0824. Int J Tuberc Lung Dis. 2021. PMID: 33688820 No abstract available.
-
Reply to "Clinical care for patients with post TB lung disease".Int J Tuberc Lung Dis. 2021 Mar 1;25(3):253-254. doi: 10.5588/ijtld.20.0903. Int J Tuberc Lung Dis. 2021. PMID: 33688821 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical